Archive
Proactive news snapshot: Rockfire Resources, SkinBioTherapeutics, 88 Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
LON:SBTX
SkinBioTherapeutics PLC is a life science company focused on skin health. The company’s proprietary platform technology, SkinBiotix ® , is based upon discoveries made at The University of Manchester.
156 stories · page 2 of 2
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Companies covered today include 88 Energy, Bagir Group, Future, Mpac, NAHL, Quadrise Fuels and Smiths Group
“Ethics approval is a prerequisite for human clinical trials and therefore required before our human study can commence”
Investments and investor services
The index of leading UK shares closed up just shy of 50 points higher at 7,676, while the FTSE 250 was also up
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A look at today's major risers and fallers in London, including Advanced Oncotherapy, Tekcapital, IDOX, RedstoneConnect, Dixons Carphone and Renold
The AIM-listed skin health company said the £600,000 grant would provide funding to investigate how ageing affects the skin and in particular, its microbiome
In the current markets, the pound fell 0.49% against the US dollar at 1.1472..
The reporting period saw the company sign a number of commercial deals of increasing value across its product range as it builds multiple revenue streams from manufacturing, application and distribution partners across the world
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London on Monday
The AIM-listed skin health company said the application covered the use of its SkinBiotix technology for increasing filaggrin levels in the skin
FTSE 250 fared better though closing ahead by around 15 points at 20,800.
With 120 women taking part, the study is double the original size
In a note to clients initiating coverage on SkinBio, the joint ‘house’ broker noted that, as the skin microbiome group operates in a new therapeutic area, there is little market data in the sector
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the top news-driven risers in London at 3.45pm ...
The cream has been formulated to contain SkinBioTherapeutics' proprietary technology, SkinBiotix; tests have proved the cream formulation retains the same beneficial properties as the original technology
FTSE 100 closed higher, as did it mid-cap cousin, FTSE 250
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of the biggest risers and fallers in London on Tuesday
The company has been speaking to a range of commercial partners interested in evaluating its SkinBiotix technology ahead of its human studies, which are scheduled to commence later this year
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of today's top risers and fallers in London
There is a growing awareness of the SkinBiotix platform technology from the skin healthcare industry
Investments and investor services
The premier UK share index closed up around 24 points at 7,281.
Archive
The numbers are not expected to contain too many surprises - which will come as a merciful relief to Lloyds' shareholders - but the bank's strategic review might provide some talking points
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the main biggest risers and fallers in London on Friday
It was another quiet day in London but also another record close
The patent covers the use of specific probiotic bacteria and lysates in the treatment of skin in health and disease
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Researchers at Charles River Laboratories assessed for photo-toxicity (sensitivity to sunlight) and ocular toxicity (effect on eye cells)
SkinBiotix recently passed an independent in-vitro (test tube) cytotoxicity safety test with flying colours
On Tuesday PureTech said affiliate Vedanta Biosciences had in-licensed microbiome-derived cancer immunotherapies based on live biotherapeutics
The company has been developing products based around the skin portion of the human microbiome
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
SSE may have rallied, but Centrica remained down in the dumps, after HSBC trimmed its price target for the British Gas owner to 190p from 202p.
The SkinBiotix platform has been developed to enhance the skin cell barrier, protect the skin and aid its regeneration
The FTSE 100 rose to within a couple of points of 7,500 after US markets opened higher
Investments and investor services
DFS in August cautioned that earnings would be at the lower end of guidance.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Nighthawk's bank has agreed to overlook the breach and Nighthawk is now considering its options. Meanwhile, Tristel has been hit by regulatory delays for a new product in the US
Its SkinBiotix cream was assessed for cellular toxicity
The pound's weakness is the source of the Footsie's late strength
Archive
Week ahead to include first half results from supermarkets giant Tesco PLC, an update from high bakery chain Greggs PLC (LON:GRG), and the latest US jobs data
The company is based around the research on the skin microbiome by chief executive Dr Cath O’Neill and her team at Manchester University.
Stephen O’Hara created Opti as a company all by himself in 2012 as a business focused on the rapidly growing microbiome space, which harnesses the positive benefits of microbes that live on the human body
Archive
A glance at some of the stories on the Proactive newswire today
The shares, listed at 9p each, were changing hands for 13.75p in early afternoon, valuing the business at a tad over £16mln.